Caption Management, LLC - RELMADA THERAPEUTICS INC ownership

RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 90 filers reported holding RELMADA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.59 and the average weighting 0.0%.

Quarter-by-quarter ownership
Caption Management, LLC ownership history of RELMADA THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$3,101,912
-82.8%
888,800
+82.3%
0.05%
-80.7%
Q3 2022$18,046,000
+38.4%
487,500
-29.0%
0.25%
+38.3%
Q2 2022$13,037,000
+4.8%
686,500
+48.9%
0.18%
+20.8%
Q1 2022$12,445,000
+345.3%
461,100
+428.2%
0.15%
+313.9%
Q2 2021$2,795,000
+381.1%
87,289
+429.4%
0.04%
+200.0%
Q1 2021$581,000
-40.4%
16,489
-34.0%
0.01%
-63.6%
Q4 2019$975,00025,0000.03%
Other shareholders
RELMADA THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Guild Investment Management, Inc. 111,550$274,4130.39%
Deep Track Capital, LP 2,837,818$6,981,0320.32%
apricus wealth, LLC 77,329$219,6140.19%
PARSONS CAPITAL MANAGEMENT INC/RI 873,312$2,148,3480.16%
Palo Alto Investors LP 732,400$1,801,7040.15%
RTW INVESTMENTS, LP 2,131,835$5,244,3140.10%
AdvisorShares Investments LLC 112,898$277,7290.08%
GSA CAPITAL PARTNERS LLP 271,524$6680.07%
Spotlight Asset Group, Inc. 20,000$49,2000.04%
Savior LLC 3,500$8,6100.04%
View complete list of RELMADA THERAPEUTICS INC shareholders